Table of Content

1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview
1.1 Product Overview and Scope of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type
1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 CH-1R Strain
1.2.3 PC Strain
1.2.4 Others
1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application
1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application: (2024-2034)
1.3.2 Gilts
1.3.3 Sows
1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts
1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2018-2034
1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2018-2034
1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competition by Manufacturers
2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
2.7 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation and Trends
2.7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue
2.7.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Retrospective Market Scenario by Region
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2034
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2023
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2024-2034
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2034
3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2023
3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2024-2034
3.4 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2034)
3.4.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2034)
3.5.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.7.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2034)
3.7.3 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2034)
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2023)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2024-2034)
4.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2018-2034)
4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2034)
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2023)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2024-2034)
4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2034)
5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2023)
5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2024-2034)
5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2018-2034)
5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2034)
5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2023)
5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2024-2034)
5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 HIPRA
6.2.1 HIPRA Corporation Information
6.2.2 HIPRA Description and Business Overview
6.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.2.5 HIPRA Recent Developments/Updates
6.3 Sinopharm Animal Health Co., Ltd
6.3.1 Sinopharm Animal Health Co., Ltd Corporation Information
6.3.2 Sinopharm Animal Health Co., Ltd Description and Business Overview
6.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.3.5 Sinopharm Animal Health Co., Ltd Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 CAVAC
6.5.1 CAVAC Corporation Information
6.5.2 CAVAC Description and Business Overview
6.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.5.5 CAVAC Recent Developments/Updates
6.6 Bioveta
6.6.1 Bioveta Corporation Information
6.6.2 Bioveta Description and Business Overview
6.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.6.5 Bioveta Recent Developments/Updates
6.7 Jinyu Bio-Technology
6.6.1 Jinyu Bio-Technology Corporation Information
6.6.2 Jinyu Bio-Technology Description and Business Overview
6.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.7.5 Jinyu Bio-Technology Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Corporation Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Chain Analysis
7.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
7.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Marketing
7.4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels
7.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
7.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
8 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
8.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
8.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. HIPRA Corporation Information
Table 76. HIPRA Description and Business Overview
Table 77. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 79. HIPRA Recent Developments/Updates
Table 80. Sinopharm Animal Health Co., Ltd Corporation Information
Table 81. Sinopharm Animal Health Co., Ltd Description and Business Overview
Table 82. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 84. Sinopharm Animal Health Co., Ltd Recent Developments/Updates
Table 85. Ceva Santé Animale Corporation Information
Table 86. Ceva Santé Animale Description and Business Overview
Table 87. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 89. Ceva Santé Animale Recent Developments/Updates
Table 90. CAVAC Corporation Information
Table 91. CAVAC Description and Business Overview
Table 92. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 94. CAVAC Recent Developments/Updates
Table 95. Bioveta Corporation Information
Table 96. Bioveta Description and Business Overview
Table 97. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 99. Bioveta Recent Developments/Updates
Table 100. Jinyu Bio-Technology Corporation Information
Table 101. Jinyu Bio-Technology Description and Business Overview
Table 102. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 104. Jinyu Bio-Technology Recent Developments/Updates
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Business Overview
Table 107. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 109. Zoetis Recent Developments/Updates
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 114. Boehringer Ingelheim Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Corporation Information
Table 116. Harbin Pharmaceutical Group Description and Business Overview
Table 117. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 119. Harbin Pharmaceutical Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List
Table 123. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List
Table 124. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends
Table 125. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
Table 126. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
Table 127. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Type in 2024 & 2034
Figure 4. CH-1R Strain Product Picture
Figure 5. PC Strain Product Picture
Figure 6. Others Product Picture
Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Application in 2024 & 2034
Figure 9. Gilts
Figure 10. Sows
Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2018-2034) & (US$ Million)
Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2018-2034) & (K Units)
Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) & (2018-2034)
Figure 15. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Report Years Considered
Figure 16. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players: Market Share by Revenue in 2024
Figure 19. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2034)
Figure 22. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2034)
Figure 23. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2034)
Figure 26. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2034)
Figure 27. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2018-2034)
Figure 34. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2034)
Figure 44. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2034)
Figure 45. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2034)
Figure 50. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type (2018-2034)
Figure 54. Global Revenue Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type (2018-2034)
Figure 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application (2018-2034)
Figure 57. Global Revenue Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application (2018-2034)
Figure 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2018-2034)
Figure 59. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain
Figure 60. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed